Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 20, 2018

Total Value ($000): $715,025 (100.0% shares, 0.0% debt)

Holdings (35)

FOUNDATION MEDICINE INC 13.1%
Value ($000) $93,640 Shares 685,000 Est. Cost $50.19 Unrealized
LOXO ONCOLOGY INC 8.7%
Value ($000) $62,453 Shares 360,000 Est. Cost $28.44 Unrealized
BLUEPRINT MEDICINES CORP 5.6%
Value ($000) $40,310 Shares 635,000 Est. Cost $49.44 Unrealized
SAGE THERAPEUTICS INC 5.5%
Value ($000) $39,133 Shares 250,000 Est. Cost $52.53 Unrealized
MYOKARDIA INC 5.4%
Value ($000) $38,727 Shares 780,000 Est. Cost $29.88 Unrealized
SPARK THERAPEUTICS INC 5.4%
Value ($000) $38,318 Shares 463,000 Est. Cost $58.74 Unrealized
BLUEBIRD BIO INC 4.4%
Value ($000) $31,390 Shares 200,000 Est. Cost $126.58 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 4.3%
Value ($000) $30,725 Shares 364,776 Est. Cost $57.83 Unrealized +50.8%
FATE FATE THERAPEUTICS INC 4.1%
Value ($000) $29,484 Shares 2,600,000 Est. Cost $4.33 Unrealized +154.5%
CDXS CODEXIS INC 4.1%
Value ($000) $29,160 Shares 2,025,000 Est. Cost $5.90 Unrealized +120.9%
MAGENTA THERAPEUTICS INC 3.8%
Value ($000) $27,484 Shares 2,035,818 Est. Cost $13.50 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 3.7%
Value ($000) $26,592 Shares 270,000 Est. Cost $85.55 Unrealized +15.9%
VYGR VOYAGER THERAPEUTICS INC 3.1%
Value ($000) $22,178 Shares 1,135,000 Est. Cost $14.86 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 3.0%
Value ($000) $21,696 Shares 480,000 Est. Cost $32.45 Unrealized
GENMARK DIAGNOSTICS INC 3.0%
Value ($000) $21,692 Shares 3,400,000 Est. Cost $6.84 Unrealized
ILMN ILLUMINA INC 2.8%
Value ($000) $19,969 Shares 71,500 Est. Cost $196.93 Unrealized +29.2%
SGMO SANGAMO THERAPEUTICS INC 2.8%
Value ($000) $19,880 Shares 1,400,000 Est. Cost $4.96 Unrealized +235.2%
AUDENTES THERAPEUTICS INC 2.4%
Value ($000) $17,195 Shares 450,000 Est. Cost $19.14 Unrealized
CRSP CRISPR THERAPEUTICS AG 1.8%
Value ($000) $12,927 Shares 220,000 Est. Cost $47.34 Unrealized +20.3%
EVH EVOLENT HEALTH INC 1.6%
Value ($000) $11,578 Shares 550,000 Est. Cost $17.59 Unrealized +7.6%
BLFS BIOLIFE SOLUTIONS INC 1.6%
Value ($000) $11,410 Shares 1,000,000 Est. Cost $9.10 Unrealized 0.0%
ONC BEIGENE LTD 1.5%
Value ($000) $10,761 Shares 70,000 Est. Cost $149.93 Unrealized
OSUR ORASURE TECHNOLOGIES INC 1.5%
Value ($000) $10,541 Shares 640,000 Est. Cost $17.66 Unrealized -4.4%
CLOVIS ONCOLOGY INC 1.4%
Value ($000) $10,003 Shares 220,000 Est. Cost $71.97 Unrealized
EDIT EDITAS MEDICINE INC 0.9%
Value ($000) $6,390 Shares 178,333 Est. Cost $24.34 Unrealized +45.5%
NEOG NEOGEN CORP 0.7%
Value ($000) $5,212 Shares 65,000 Est. Cost $30.13 Unrealized +22.4%
CTMX CYTOMX THERAPEUTICS INC 0.7%
Value ($000) $4,743 Shares 207,500 Est. Cost $17.02 Unrealized +50.1%
NEON THERAPEUTICS INC 0.6%
Value ($000) $4,263 Shares 338,345 Est. Cost $12.60 Unrealized
LOXO ONCOLOGY INC 0.5%
Value ($000) $3,470 Shares 20,000 Est. Cost $28.44 Unrealized
ZLAB ZAI LAB LTD 0.4%
Value ($000) $3,139 Shares 135,000 Est. Cost $21.35 Unrealized
JOUNCE THERAPEUTICS INC 0.4%
Value ($000) $2,873 Shares 375,000 Est. Cost $18.19 Unrealized
CDNA CAREDX INC 0.3%
Value ($000) $2,448 Shares 200,000 Est. Cost $11.47 Unrealized 0.0%
HOMOLOGY MEDICINES INC 0.3%
Value ($000) $2,346 Shares 115,000 Est. Cost $19.51 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 0.3%
Value ($000) $2,260 Shares 50,000 Est. Cost $32.45 Unrealized
BLUEPRINT MEDICINES CORP 0.1%
Value ($000) $635 Shares 10,000 Est. Cost $49.44 Unrealized